Shares of HealthSouth Corp (NYSE:HLS) have been given a consensus rating of “Hold” by the ten ratings firms that are presently covering the stock, Analyst Ratings Net reports. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and four have given a buy rating to the company. The average 1-year target price among analysts that have updated their coverage on the stock in the last year is $45.44.

A number of research firms have commented on HLS. Barclays reaffirmed an “equal weight” rating and issued a $39.00 price objective (down previously from $42.00) on shares of HealthSouth Corp in a report on Friday, October 30th. JMP Securities decreased their price objective on shares of HealthSouth Corp from $54.00 to $44.00 and set a “market outperform” rating for the company in a report on Monday, November 2nd. Mizuho decreased their price objective on shares of HealthSouth Corp from $50.00 to $40.00 and set a “buy” rating for the company in a report on Thursday, October 29th. Wedbush decreased their price objective on shares of HealthSouth Corp from $51.00 to $45.00 and set a “neutral” rating for the company in a report on Friday, November 6th. Finally, RBC Capital decreased their price objective on shares of HealthSouth Corp from $51.00 to $45.00 in a report on Friday, October 30th.

In related news, Director John Chidsey acquired 799 shares of the business’s stock in a transaction that occurred on Monday, January 11th. The shares were acquired at an average cost of $35.78 per share, for a total transaction of $28,588.22. Following the completion of the purchase, the director now directly owns 88,412 shares in the company, valued at $3,163,381.36. The acquisition was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Joan E. Herman acquired 1,000 shares of the business’s stock in a transaction that occurred on Thursday, November 5th. The shares were bought at an average price of $35.28 per share, for a total transaction of $35,280.00. Following the completion of the purchase, the director now owns 13,590 shares of the company’s stock, valued at $479,455.20. The disclosure for this purchase can be found here.

Several large investors recently modified their holdings of HLS. Saddle Road Partners bought a new stake in shares of HealthSouth Corp during the fourth quarter worth $566,000. ICON Advisers bought a new stake in shares of HealthSouth Corp during the third quarter worth $652,000. Finally, Nisa Investment Advisors boosted its stake in shares of HealthSouth Corp by 11.3% in the fourth quarter. Nisa Investment Advisors now owns 34,400 shares of the company’s stock worth $1,197,000 after buying an additional 3,500 shares in the last quarter.

Shares of HealthSouth Corp (NYSE:HLS) opened at 35.79 on Friday. HealthSouth Corp has a 12-month low of $32.30 and a 12-month high of $48.37. The firm has a market cap of $3.27 billion and a PE ratio of 19.34. The company has a 50 day moving average price of $34.51 and a 200-day moving average price of $38.64.

HealthSouth Corporation (NYSE:HLS) is an owner and operator of inpatient rehabilitation hospitals. The Company’s inpatient rehabilitation hospitals offer rehabilitative care across an array of diagnoses, which include physical and cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, head injuries, spinal cord injuries and a variety of debilitating neurological conditions. HealthSouth operates in around 33 states across the United States and in Puerto Rico and serves patients through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company’s inpatient rehabilitation hospitals offer rehabilitative care across an array of diagnoses. As of December 31, 2014, the Company operated 107 inpatient rehabilitation hospitals. The Company’s inpatient hospitals are concentrated in the eastern half of the United States and Texas.

12 Month Chart for NYSE:HLS

Receive News & Ratings for HealthSouth Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth Corp and related companies with MarketBeat.com's FREE daily email newsletter.